LH Overview — StockExplainer

+114%

+7.9% per year

Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.

Country US

Exchange NYSE

Industry Medical - Diagnostics & Research

Sector Healthcare

Market Cap $19.23B

CEO Mr. Adam H. Schechter

Laboratory Corporation of America Holdings, often called Labcorp, is a healthcare company that helps doctors and patients by providing important medical tests. They offer a wide range of tests, like those for blood and urine, to help diagnose health issues and monitor diseases. Labcorp also works with drug companies to develop new medicines and medical devices. Overall, they play a crucial role in ensuring people get the right information about their health.

Streams of revenue

LabCorp Diagnostics: 78%

Covance Drug Development: 22%

Geographic Distribution

UNITED STATES: 100%

Core Products

🧬

Genetic Testing DNA analysis

💊

Drug Development Pharma R&D support

🔬

Pathology Services Disease diagnosis

☣️

Toxicology Testing Substance analysis

🧪

Clinical Lab Testing Diagnostic tests

Business Type

Business to Business

Competitive Advantages

🌍

Diverse Client Base Labcorp serves a broad array of clients, including hospitals, pharmaceutical companies, and governmental agencies, reducing dependency on any single market segment.

🤝

Strategic Partnerships Collaborations, such as with the Tigerlily Foundation, enhance Labcorp's capabilities and position in the market, particularly in clinical trial diversity.

⭐

Strong Brand Reputation As a well-established leader in the diagnostics industry, Labcorp's brand is trusted by healthcare professionals and patients alike.

🧪

Comprehensive Test Portfolio Labcorp offers a wide range of diagnostic tests and specialty services, providing a one-stop solution for healthcare providers and patients.

🔬

Advanced Technology and Innovation Investment in cutting-edge technology and gene-based testing allows Labcorp to stay ahead in the rapidly evolving medical diagnostics sector.

Key Business Risks

🔒

Data Security Sensitive patient data is at risk of breaches, leading to legal liabilities and loss of trust.

📉

Economic Downturns Economic fluctuations can reduce healthcare spending, affecting demand for diagnostic and research services.

🏆

Market Competition Intense competition from other diagnostic and research companies may erode market share and profitability.

⚖️

Regulatory Compliance Changes in healthcare regulations and compliance requirements can affect operations and increase costs.

💻

Technological Advancements Rapid technological changes may require continuous investment in new equipment and training, impacting margins.

Meeting Expectations

8 /10

Higher values indicate better execution and credibility

Recent Results

2025-02-06

2024-10-24

2024-08-01

2024-04-25

2024-02-15

2023-10-26

2023-07-27

2023-04-25

2023-02-16

2022-10-27

Takeaways

Laboratory Corporation of America Holdings benefits from a diverse range of diagnostic services and a strong market position, supported by robust financial health and growth potential in the healthcare sector. However, it faces risks from regulatory changes and competition in a rapidly evolving industry.

Historical data shows an impressive CAGR compared with the USA stock market average, reflecting a strong market position.

10Y annualized return is positive but below market average at 7.9% per year

LH has met or exceeded earnings expectations in the majority of recent quarters (8/10)

Continue with...

Business Overview

Performance Analysis

Stock Price

Performance Analysis

Stock Price